The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Sana Biotechnology Inc (NASDAQ: SANA) closed at $4.95 up 1.02% from its previous closing price of $4.9. In other words, the price has increased by $1.02 from its previous closing price. On the day, 4.39 million shares were traded. SANA stock price reached its highest trading level at $4.995 during the session, while it also had its lowest trading level at $4.79.
Ratios:
For a deeper understanding of Sana Biotechnology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Wedbush on September 24, 2025, initiated with a Outperform rating and assigned the stock a target price of $5.
Citizens JMP Upgraded its Mkt Perform to Mkt Outperform on March 18, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 18 ’25 when CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares for $3.16 per share.
CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares of SANA for $289,500 on Jan 16 ’25. On Jan 08 ’25, another insider, FMR LLC, who serves as The insider 1 of the company, sold 290,912 shares for $6.49 each. As a result, the insider received 1,887,320 and left with 4,541,511 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 1273389824 and an Enterprise Value of 1189960192.
Stock Price History:
The Beta on a monthly basis for SANA is 1.94, which has changed by 0.31648934 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, SANA has reached a high of $7.30, while it has fallen to a 52-week low of $1.26. The 50-Day Moving Average of the stock is 24.58%, while the 200-Day Moving Average is calculated to be 61.35%.
Shares Statistics:
For the past three months, SANA has traded an average of 5.43M shares per day and 4999270 over the past ten days. A total of 230.51M shares are outstanding, with a floating share count of 161.12M. Insiders hold about 37.72% of the company’s shares, while institutions hold 44.04% stake in the company. Shares short for SANA as of 1760486400 were 30604555 with a Short Ratio of 5.64, compared to 1757894400 on 28830247. Therefore, it implies a Short% of Shares Outstanding of 30604555 and a Short% of Float of 34.55.
Earnings Estimates
The stock of Sana Biotechnology Inc (SANA) is currently being evaluated by 4.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.66 and -$0.86 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.61, with 4.0 analysts recommending between -$0.51 and -$0.66.
